Answers are grounded in this paper and cite their sources.
Assesses the diagnostic performance of KFLC-Index for distinguishing MOGAD, NMOSD, and MS, indicating its potential clinical utility.
The differential diagnosis between aquaporin-4-immunoglobulin G–positive neuromyelitis optica spectrum disorder (AQP4-NMOSD), myelin oligodendrocyte glycoprotein (MOG) antibody–associated disease (MOGAD), and multiple sclerosis (MS) can be complex. Kappa free light chain index (KFLC-Index) emerged as an effective biomarker for distinguishing patients with MS from patients with other conditions. The main aim of this study was to assess the diagnostic performance of KFLC-Index in differentiating MOGAD, AQP4-NMOSD, and MS and to compare it with CSF-restricted oligoclonal bands (OCB) performance.
No takes yet. Share an insight, caveat, or question.
Tournier et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: